Influence of the interval between the administration of doxorubicin and paclitaxel on the pharmacokinetics of these drugs in patients with locally advanced breast cancer
✍ Scribed by António Moreira; Rosário Lobato; José Morais; Sandra Silva; Josefa Ribeiro; Ana Figueira; Dina Vale; Carla Sousa; Fátima Araújo; Aires Fernandes; João Oliveira; José Passos-Coelho
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 103 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. The authors compared the pharmacokinetics of doxorubicin when administered with and without concomitant high dose cyclosporine for multidrug resistant (MDR) tumor modulation in small cell lung cancer. Methods. Eight patients with small cell lung cancer served as their own controls and w
## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate